The production line of nearly 300 million yuan invested by Puluo pharmaceutical industry was closed without any clarification
-
Last Update: 2018-12-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Yesterday (December 4), pulo Pharmaceutical Co., Ltd issued a Clarification Announcement on the report titled "shut down the production line with an investment of nearly 300 million yuan without concealing" recently published by relevant media of pulo Pharmaceutical Co., Ltd on the Internet According to the announcement, the total investment of the two chemical synthesis production lines did not reach 293 million yuan as reported by pulo pharmaceutical Because the transfer of the number of ofloxacin and levofloxacin has not been completed, the two chemical synthesis production lines have not been formally put into commercial production, and there is no "stop production" statement The following is the full text of the announcement:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.